Skip to main content
NIBEC CO., LTD. logo

NIBEC CO., LTD. — Investor Relations & Filings

Ticker · 138610 ISIN · KR7138610001 KO Manufacturing
Open in API
Filings indexed 218 across all filing types
Latest filing 2020-03-30 Audit Report / Informat…
Country KR South Korea
Listing KO 138610

About NIBEC CO., LTD.

https://nibec.co.kr/en/

NIBEC CO., LTD. is a biotechnology company specializing in the research, development, and commercialization of healthcare solutions centered on proprietary peptide technology. The company's core activities involve the manufacturing of tissue regenerative biomaterials, such as dental bone grafts and collagen-based products, as well as biomaterial-based medical devices. In addition to its focus on regenerative medicine, NIBEC develops and markets a range of dental care and cosmetic products. The company is also actively engaged in the research and development of novel peptide-based drugs and bio-fusion technologies to address various therapeutic needs.

Recent filings

Filing Released Lang Actions
사업보고서 (2019.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for the company 'NIBEC' (주식회사 나이벡) for the fiscal year ending December 31, 2019. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. This is a full financial audit report, not an earnings release or a summary, and it is clearly distinct from an Annual Report (10-K) as it focuses specifically on the audit and financial statements. FY 2019
2020-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results from a General Meeting of Shareholders (Annual General Meeting). It details the approval of financial statements, election of directors and auditors, and other resolutions passed during the meeting held on 2020-03-27. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2020-03-27 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options). It details the issuance of stock options to directors, auditors, and employees, including the number of shares, exercise price, and valuation methodology. This type of disclosure regarding capital structure changes and equity-based compensation for executives and employees falls under the category of 'Share Issue/Capital Change' (SHA) in the provided classification schema, as it relates to the issuance of new shares or rights to shares.
2020-03-27 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by the company RNL Bio (나이벡). It provides the auditor's opinion (unqualified/proper), key financial data (assets, liabilities, equity, profit/loss), and details regarding capital impairment and operating losses. While it contains financial data, it is a standalone regulatory filing specifically announcing the submission of the audit report to the exchange, rather than the full 10-K annual report itself. Therefore, it fits the 'Audit Report / Information' category. FY 2019
2020-03-18 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Audit Report / Information Classification · 95% confidence The document is a regulatory filing from a Korean company (NIBEC) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement in the Korean stock market (KRX) for material financial changes. Since it provides specific financial highlights and performance metrics rather than just announcing the release of a report, it falls under the 'Earnings Release' category as it serves as the initial announcement of financial results. FY 2019
2020-03-10 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company 'NIBEC'. It outlines the date, location, and agenda items (such as approval of financial statements, election of directors, and changes to business purposes). This type of document is a standard proxy solicitation material sent to shareholders to inform them of the upcoming meeting and request their participation/votes, which falls under the Proxy Solicitation & Information Statement category.
2020-03-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.